These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 11313925)

  • 1. Constitutive c-Myb amino-terminal phosphorylation and DNA binding activity uncoupled during entry and passage through the cell cycle.
    Cures A; House C; Kanei-Ishii C; Kemp B; Ramsay RG
    Oncogene; 2001 Mar; 20(14):1784-92. PubMed ID: 11313925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of transcription factors c-Myc, Max, and c-Myb by casein kinase II.
    Bousset K; Oelgeschläger MH; Henriksson M; Schreek S; Burkhardt H; Litchfield DW; Lüscher-Firzlaff JM; Lüscher B
    Cell Mol Biol Res; 1994; 40(5-6):501-11. PubMed ID: 7735324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of c-Myb through protein phosphorylation and leucine zipper interactions.
    Ramsay RG; Morrice N; Van Eeden P; Kanagasundaram V; Nomura T; De Blaquiere J; Ishii S; Wettenhall R
    Oncogene; 1995 Nov; 11(10):2113-20. PubMed ID: 7478531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
    Bessa M; Saville MK; Watson RJ
    Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation.
    Lüscher B; Christenson E; Litchfield DW; Krebs EG; Eisenman RN
    Nature; 1990 Apr; 344(6266):517-22. PubMed ID: 2157164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIPK1 interacts with c-Myb and modulates its activity through phosphorylation.
    Matre V; Nordgård O; Alm-Kristiansen AH; Ledsaak M; Gabrielsen OS
    Biochem Biophys Res Commun; 2009 Oct; 388(1):150-4. PubMed ID: 19646965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linking Myb to the cell cycle: cyclin-dependent phosphorylation and regulation of A-Myb activity.
    Ziebold U; Klempnauer KH
    Oncogene; 1997 Aug; 15(9):1011-9. PubMed ID: 9285555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-myb stimulates cell growth by regulation of insulin-like growth factor (IGF) and IGF-binding protein-3 in K562 leukemia cells.
    Kim MS; Kim SY; Arunachalam S; Hwang PH; Yi HK; Nam SY; Lee DY
    Biochem Biophys Res Commun; 2009 Jul; 385(1):38-43. PubMed ID: 19427836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperphosphorylation and increased proteolytic breakdown of c-Myb induced by the inhibition of Ser/Thr protein phosphatases.
    Bies J; Feiková S; Bottaro DP; Wolff L
    Oncogene; 2000 Jun; 19(24):2846-54. PubMed ID: 10851088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumorigenic N-terminal deletions of c-Myb modulate DNA binding, transactivation, and cooperativity with C/EBP.
    Oelgeschläger M; Kowenz-Leutz E; Schreek S; Leutz A; Lüscher B
    Oncogene; 2001 Nov; 20(50):7420-4. PubMed ID: 11704872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.
    Nagy ZS; Wang Y; Erwin-Cohen RA; Aradi J; Monia B; Wang LH; Stepkowski SM; Rui H; Kirken RA
    J Leukoc Biol; 2002 Oct; 72(4):819-28. PubMed ID: 12377952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-Myb repressor function is regulated by cyclin A phosphorylation and sequences within the C-terminal domain.
    Petrovas C; Jeay S; Lewis RE; Sonenshein GE
    Oncogene; 2003 Apr; 22(13):2011-20. PubMed ID: 12673206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the cell cycle by B-Myb.
    Bessa M; Joaquin M; Tavner F; Saville MK; Watson RJ
    Blood Cells Mol Dis; 2001; 27(2):416-21. PubMed ID: 11259164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p38MAPK delta controls c-Myb degradation in response to stress.
    Pani E; Ferrari S
    Blood Cells Mol Dis; 2008; 40(3):388-94. PubMed ID: 18006338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase CK2 activates the atypical Rio1p kinase and promotes its cell-cycle phase-dependent degradation in yeast.
    Angermayr M; Hochleitner E; Lottspeich F; Bandlow W
    FEBS J; 2007 Sep; 274(17):4654-67. PubMed ID: 17725716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA binding-independent transcriptional activation of the vascular endothelial growth factor gene (VEGF) by the Myb oncoprotein.
    Lutwyche JK; Keough RA; Hunter J; Coles LS; Gonda TJ
    Biochem Biophys Res Commun; 2006 Jun; 344(4):1300-7. PubMed ID: 16650815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
    Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
    Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone H3 tail positioning and acetylation by the c-Myb but not the v-Myb DNA-binding SANT domain.
    Mo X; Kowenz-Leutz E; Laumonnier Y; Xu H; Leutz A
    Genes Dev; 2005 Oct; 19(20):2447-57. PubMed ID: 16195416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Myb-dependent inositol 1,4,5-trisphosphate receptor type-1 expression in vascular smooth muscle cells.
    Afroze T; Sadi AM; Momen MA; Gu S; Heximer S; Husain M
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1305-11. PubMed ID: 17363689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FLASH acts as a co-activator of the transcription factor c-Myb and localizes to active RNA polymerase II foci.
    Alm-Kristiansen AH; Saether T; Matre V; Gilfillan S; Dahle O; Gabrielsen OS
    Oncogene; 2008 Aug; 27(34):4644-56. PubMed ID: 18408764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.